Acadian Asset Management LLC Has $2.72 Million Holdings in Cigna Group $CI

Acadian Asset Management LLC boosted its holdings in Cigna Group (NYSE:CI) by 277.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,274 shares of the health services provider’s stock after buying an additional 6,082 shares during the period. Acadian Asset Management LLC’s holdings in Cigna Group were worth $2,718,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Family Legacy Inc. increased its holdings in Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after purchasing an additional 31 shares during the last quarter. Impact Investors Inc boosted its stake in Cigna Group by 1.6% during the 1st quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock worth $650,000 after acquiring an additional 31 shares during the last quarter. Mission Wealth Management LP grew its holdings in Cigna Group by 1.5% during the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after purchasing an additional 32 shares during the period. Westend Capital Management LLC increased its stake in Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after purchasing an additional 32 shares in the last quarter. Finally, Moody National Bank Trust Division raised its holdings in Cigna Group by 0.7% in the first quarter. Moody National Bank Trust Division now owns 4,587 shares of the health services provider’s stock worth $1,509,000 after purchasing an additional 34 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 1.8%

Shares of NYSE:CI opened at $297.31 on Tuesday. The company’s 50-day moving average price is $295.15 and its two-hundred day moving average price is $312.02. Cigna Group has a one year low of $256.89 and a one year high of $370.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The stock has a market capitalization of $79.36 billion, a PE ratio of 16.23, a price-to-earnings-growth ratio of 0.89 and a beta of 0.48.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Truist Financial set a $375.00 price objective on shares of Cigna Group in a research report on Tuesday, September 2nd. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 price target on shares of Cigna Group in a research report on Tuesday, August 26th. Guggenheim reiterated a “buy” rating and issued a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $374.76.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.70% of the stock is owned by corporate insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.